Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA

Clinical Rheumatology

Volumn 28, Issue 5, 2009, Pages 611-613

  Gizinski, Alison M ^a   Mascolo, Margherita ^b   Loucks, Jennifer L ^b   Kervitsky, Alma ^c   Meehan, Richard T ^c   Brown, Kevin K ^c   Holers, V Michael ^b   Deane, Kevin D ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

Anti cyclic citrullinated peptide (anti CCP) antibodies; Interstitial lung disease; Rheumatoid arthritis; Rheumatoid arthritis pathogenesis; Rheumatoid factor (RF)

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR;

AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SMOKING;

AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; RETROSPECTIVE STUDIES; RHEUMATOLOGY; SMOKING; TREATMENT OUTCOME;

EID: 64449083863     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1128-9     Document Type: Article

References (13)

1. Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 65(7):845-851
2. Nielen MM et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 50(2):380-386
3. Metafratzi ZM et al (2007) Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 36(5):338-444
4. Gabbay E et al (1997) Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 156(2 Pt 1):528-535
5. Oliver JE, Silman AJ (2006) Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 35(3):169-174
6. Arnett FC et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324
7. Elkayam O et al (2007) Auto-antibody profiles in patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis 11(3):306-310
8. Bowes J, Barton A (2008) Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 47(4):399-402
9. Klareskog L et al (2006) A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54(1):38-46
10. Alexiou I et al (2008) Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 27(4):511-513
11. Brannan HM et al (1964) Pulmonary disease associated with rheumatoid arthritis. JAMA 189:914-918
12. Gottlieb AJ et al (1965) Serologic factors in idiopathic diffuse interstitial pulmonary fibrosis. Am J Med 39:405-410
13. Makrygiannakis D et al (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67(10):1488-1492